IRON Insider Transactions — Page 7
681 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 601–681; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Atlas Venture Associates Opportunity I, L.P. | TenPercentOwner | 2023-08-15 | Sale | 72,931.0 | $52.4 |
| Atlas Venture Associates Opportunity I, LLC | TenPercentOwner | 2023-08-15 | Sale | 72,931.0 | $52.4 |
| Atlas Venture Fund X, L.P. | TenPercentOwner | 2023-08-15 | Sale | 111,069.0 | $52.4 |
| Atlas Venture Associates X, LLC | TenPercentOwner | 2023-08-15 | Sale | 111,069.0 | $52.4 |
| ATLAS VENTURE ASSOCIATES X, L.P. | TenPercentOwner | 2023-08-15 | Sale | 111,069.0 | $52.4 |
| Atlas Venture Opportunity Fund I, L.P. | TenPercentOwner | 2023-08-15 | Sale | 111,069.0 | $52.4 |
| Atlas Venture Associates Opportunity I, L.P. | TenPercentOwner | 2023-08-15 | Sale | 111,069.0 | $52.4 |
| Atlas Venture Associates Opportunity I, LLC | TenPercentOwner | 2023-08-15 | Sale | 111,069.0 | $52.4 |
| Savage William Jacob | Chief Medical Officer | 2023-08-15 | Sale | 1,839.0 | $53.96 |
| Savage William Jacob | Chief Medical Officer | 2023-08-15 | Sale | 2,125.0 | $53.26 |
| Savage William Jacob | Chief Medical Officer | 2023-08-15 | Sale | 3,708.0 | $52.27 |
| Atlas Venture Fund X, L.P. | TenPercentOwner | 2023-08-14 | Sale | 2,000.0 | $54.8 |
| Atlas Venture Associates X, LLC | TenPercentOwner | 2023-08-14 | Sale | 2,000.0 | $54.8 |
| ATLAS VENTURE ASSOCIATES X, L.P. | TenPercentOwner | 2023-08-14 | Sale | 2,000.0 | $54.8 |
| Atlas Venture Opportunity Fund I, L.P. | TenPercentOwner | 2023-08-14 | Sale | 2,000.0 | $54.8 |
| Atlas Venture Associates Opportunity I, L.P. | TenPercentOwner | 2023-08-14 | Sale | 2,000.0 | $54.8 |
| Atlas Venture Associates Opportunity I, LLC | TenPercentOwner | 2023-08-14 | Sale | 2,000.0 | $54.8 |
| Atlas Venture Fund X, L.P. | TenPercentOwner | 2023-08-14 | Sale | 98,000.0 | $53.0 |
| Atlas Venture Associates X, LLC | TenPercentOwner | 2023-08-14 | Sale | 98,000.0 | $53.0 |
| ATLAS VENTURE ASSOCIATES X, L.P. | TenPercentOwner | 2023-08-14 | Sale | 98,000.0 | $53.0 |
| Atlas Venture Opportunity Fund I, L.P. | TenPercentOwner | 2023-08-14 | Sale | 98,000.0 | $53.0 |
| Atlas Venture Associates Opportunity I, L.P. | TenPercentOwner | 2023-08-14 | Sale | 98,000.0 | $53.0 |
| Atlas Venture Associates Opportunity I, LLC | TenPercentOwner | 2023-08-14 | Sale | 98,000.0 | $53.0 |
| Atlas Venture Fund X, L.P. | TenPercentOwner | 2023-08-14 | Sale | 75,000.0 | $52.0 |
| Atlas Venture Associates X, LLC | TenPercentOwner | 2023-08-14 | Sale | 75,000.0 | $52.0 |
| ATLAS VENTURE ASSOCIATES X, L.P. | TenPercentOwner | 2023-08-14 | Sale | 75,000.0 | $52.0 |
| Atlas Venture Opportunity Fund I, L.P. | TenPercentOwner | 2023-08-14 | Sale | 75,000.0 | $52.0 |
| Atlas Venture Associates Opportunity I, L.P. | TenPercentOwner | 2023-08-14 | Sale | 75,000.0 | $52.0 |
| Atlas Venture Associates Opportunity I, LLC | TenPercentOwner | 2023-08-14 | Sale | 75,000.0 | $52.0 |
| Savage William Jacob | Chief Medical Officer | 2023-08-09 | Sale | 1,481.0 | $50.91 |
| Savage William Jacob | Chief Medical Officer | 2023-08-09 | Sale | 3,588.0 | $50.22 |
| Savage William Jacob | Chief Medical Officer | 2023-08-09 | Sale | 3,200.0 | $48.9 |
| Bryce Joanne | Chief Financial Officer | 2023-08-01 | Sale | 1,454.0 | $50.5 |
| Bryce Joanne | Chief Financial Officer | 2023-08-01 | Sale | 3,067.0 | $49.63 |
| MacDonald Brian Richard | Chief Innovation Officer | 2023-06-30 | Sale | 600.0 | $46.76 |
| MacDonald Brian Richard | Chief Innovation Officer | 2023-06-30 | Sale | 1,401.0 | $45.45 |
| MacDonald Brian Richard | Chief Innovation Officer | 2023-06-30 | Sale | 2,923.0 | $44.85 |
| MacDonald Brian Richard | Chief Innovation Officer | 2023-06-29 | Sale | 200.0 | $47.24 |
| MacDonald Brian Richard | Chief Innovation Officer | 2023-06-29 | Sale | 1,934.0 | $46.51 |
| MacDonald Brian Richard | Chief Innovation Officer | 2023-06-29 | Sale | 2,230.0 | $45.49 |
| MacDonald Brian Richard | Chief Innovation Officer | 2023-06-29 | Sale | 736.0 | $44.37 |
| MacDonald Brian Richard | Chief Innovation Officer | 2023-06-28 | Sale | 953.0 | $50.8 |
| MacDonald Brian Richard | Chief Innovation Officer | 2023-06-28 | Sale | 1,900.0 | $50.38 |
| MacDonald Brian Richard | Chief Innovation Officer | 2023-06-28 | Sale | 2,247.0 | $49.24 |
| Bryce Joanne | Chief Financial Officer | 2023-06-28 | Sale | 359.0 | $51.23 |
| Bryce Joanne | Chief Financial Officer | 2023-06-28 | Sale | 4,905.0 | $50.5 |
| Bryce Joanne | Chief Financial Officer | 2023-06-28 | Sale | 4,808.0 | $49.3 |
| Savage William Jacob | Chief Medical Officer | 2023-06-28 | Sale | 1,564.0 | $50.72 |
| Savage William Jacob | Chief Medical Officer | 2023-06-28 | Sale | 1,300.0 | $50.0 |
| Savage William Jacob | Chief Medical Officer | 2023-06-28 | Sale | 1,520.0 | $49.2 |
| Novo Holdings A/S | TenPercentOwner | 2023-06-28 | Sale | 1,250,000.0 | $46.1 |
| Blavatnik Len | TenPercentOwner | 2023-02-15 | Purchase | 434,783.0 | $23.0 |
| Access Industries Holdings LLC | TenPercentOwner | 2023-02-15 | Purchase | 434,783.0 | $23.0 |
| ACCESS INDUSTRIES MANAGEMENT, LLC | TenPercentOwner | 2023-02-15 | Purchase | 434,783.0 | $23.0 |
| AI DMI LLC | TenPercentOwner | 2023-02-15 | Purchase | 434,783.0 | $23.0 |
| Ashiya Mona | Director,TenPercentOwner | 2023-02-15 | Purchase | 14,329.0 | $23.0 |
| Ashiya Mona | Director,TenPercentOwner | 2023-02-15 | Purchase | 37,049.0 | $23.0 |
| Ashiya Mona | Director,TenPercentOwner | 2023-02-15 | Purchase | 57,318.0 | $23.0 |
| ORBIMED ADVISORS LLC | Director,TenPercentOwner | 2023-02-15 | Purchase | 14,329.0 | $23.0 |
| OrbiMed Capital GP VI LLC | Director,TenPercentOwner | 2023-02-15 | Purchase | 14,329.0 | $23.0 |
| OrbiMed Genesis GP LLC | Director,TenPercentOwner | 2023-02-15 | Purchase | 14,329.0 | $23.0 |
| OrbiMed Capital GP VIII LLC | Director,TenPercentOwner | 2023-02-15 | Purchase | 14,329.0 | $23.0 |
| ORBIMED ADVISORS LLC | Director,TenPercentOwner | 2023-02-15 | Purchase | 37,049.0 | $23.0 |
| OrbiMed Capital GP VI LLC | Director,TenPercentOwner | 2023-02-15 | Purchase | 37,049.0 | $23.0 |
| OrbiMed Genesis GP LLC | Director,TenPercentOwner | 2023-02-15 | Purchase | 37,049.0 | $23.0 |
| OrbiMed Capital GP VIII LLC | Director,TenPercentOwner | 2023-02-15 | Purchase | 37,049.0 | $23.0 |
| ORBIMED ADVISORS LLC | Director,TenPercentOwner | 2023-02-15 | Purchase | 57,318.0 | $23.0 |
| OrbiMed Capital GP VI LLC | Director,TenPercentOwner | 2023-02-15 | Purchase | 57,318.0 | $23.0 |
| OrbiMed Genesis GP LLC | Director,TenPercentOwner | 2023-02-15 | Purchase | 57,318.0 | $23.0 |
| OrbiMed Capital GP VIII LLC | Director,TenPercentOwner | 2023-02-15 | Purchase | 57,318.0 | $23.0 |
| Leonard Braden Michael | TenPercentOwner | 2022-10-26 | Sale | 22,500.0 | $2.09 |
| Leonard Braden Michael | TenPercentOwner | 2022-04-13 | Purchase | 191,769.0 | $1.52 |
| Leonard Braden Michael | TenPercentOwner | 2022-04-12 | Purchase | 203,744.0 | $1.42 |
| Leonard Braden Michael | TenPercentOwner | 2022-04-12 | Purchase | 55,000.0 | $1.37 |
| Leonard Braden Michael | TenPercentOwner | 2022-04-11 | Purchase | 504,487.0 | $1.35 |
| Piekos Brian | Chief Financial Officer | 2021-05-14 | Purchase | 7,655.0 | $9.46 |
| Meyenburg Jason Patrick | President & CEO | 2021-05-14 | Purchase | 13,000.0 | $9.46 |
| Tananbaum James B. | President & CEO | 2020-08-14 | Purchase | 441,500.0 | $10.0 |
| Foresite Capital Fund V, L.P. | TenPercentOwner | 2020-08-14 | Purchase | 441,500.0 | $10.0 |
| Foresite Capital Management V, LLC | TenPercentOwner | 2020-08-14 | Purchase | 441,500.0 | $10.0 |
| FS Development Holdings, LLC | TenPercentOwner | 2020-08-14 | Purchase | 441,500.0 | $10.0 |